Kate Li

Kate Li has a diverse work experience spanning over several companies and industries. Kate started their career in 1995 as a Senior Statistician at Johnson & Johnson and Roche before joining Prudential Healthcare as a Senior Database Manager in 1998. In 1999, they became a Senior Manager at American Express before moving on to JPMorgan Chase & Co. as a Vice President in 2000. At JPMorgan, they managed a team of analysts and led projects related to pricing strategy and analysis. In 2006, Kate transitioned to the FDA as a Mathematical Statistician, where they conducted numerous NDA reviews and gained expertise in various drugs and treatments. Kate worked at the FDA for 14 years before joining Taiho Oncology, Inc. as a Director in 2020. In this role, they focused on designing statistical aspects for clinical trials and leading the statistical aspects of global NDA submissions. Kate briefly served as the Executive Director at PTC Therapeutics, Inc. in 2022 before becoming the Head of Biostatistics at Actinium Pharmaceuticals, Inc. in 2023.

Kate Li holds a Doctor of Philosophy (PhD) degree in Biostatistics from Columbia University. Kate also has a Master of Science (MS) degree in Statistics from the University at Buffalo. Kate'sundergraduate education includes a Bachelor of Science (B.S.) degree in Mathematics from the University of Science and Technology of China.